Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

2.330

+0.030 (1.30%)

At close: Jun 9, 2026, 4:00 PM EDT

2.290

-0.040 (-1.72%)

After-hours: Jun 9, 2026, 6:10 PM EDT

Grace Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	18.67	22.13	23.01	27.88	30.34	50.94
Short-Term Investments	-	-	-	0.02	13.32	9.79
Cash & Short-Term Investments	18.67	22.13	23.01	27.89	43.66	60.73
Cash Growth	68.90%	-3.79%	-17.52%	-36.12%	-28.11%	326.48%
Accounts Receivable	0.02	0.13	0.72	0.8	0.55	0.53
Other Current Assets	0.52	0.45	0.28	0.6	1.07	1.11
Total Current Assets	19.21	22.71	24.01	29.29	45.28	62.37
Net Property, Plant & Equipment	0.01	0.02	0.02	0.57	0.57	0.09
Other Intangible Assets	41.13	41.13	41.13	41.13	69.81	-
Goodwill	8.14	8.14	8.14	8.14	12.96	-
Total Assets	68.49	71.99	73.3	79.12	128.62	62.46
Accounts Payable	1.28	1.93	1.68	3.34	3.16	1.49
Current Portion of Leases	-	-	-	0.08	0.1	0.09
Total Current Liabilities	1.28	1.93	1.68	3.41	3.26	1.58
Long-Term Leases	-	-	-	0.41	0.19	-
Other Long-Term Liabilities	2.31	3.45	9.87	7.35	16.9	5.22
Total Long-Term Liabilities	2.31	3.45	9.87	7.76	17.09	5.22
Total Liabilities	3.6	5.38	11.56	11.17	20.35	6.8
Common Stock	0	0	261.04	258.29	257.99	197.19
Additional Paid-in Capital	298.23	293.33	17.86	13.97	12.15	10.82
Accumulated Other Comprehensive Income	-6.04	-6.04	-6.04	-6.04	-6.04	-6.33
Retained Earnings	-227.3	-220.69	-211.12	-198.27	-155.84	-146.02
Shareholders' Equity	64.89	66.61	61.74	67.96	108.27	55.66
Total Liabilities & Equity	68.49	71.99	73.3	79.12	128.62	62.46
Total Debt	-	0	0	0.49	0.3	0.09
Net Cash (Debt)	18.67	22.13	23.01	27.41	43.37	60.65
Net Cash Growth	-15.64%	-3.79%	-16.05%	-36.80%	-28.49%	330.32%
Net Cash Per Share	1.19	1.83	2.41	3.69	7.06	24.54
Book Value	64.89	66.61	61.74	67.96	108.27	55.66
Book Value Per Share	4.15	5.51	6.48	9.14	17.63	22.52
Tangible Book Value	15.63	17.34	12.48	18.69	25.5	55.66
Tangible Book Value Per Share	1.00	1.43	1.31	2.51	4.15	22.52

SEC Filings: 10-K · 10-Q